| 000 | 03155nam a22005775i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-11284-3 | ||
| 003 | DE-He213 | ||
| 005 | 20240730164815.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 220927s2022 sz | s |||| 0|eng d | ||
| 020 |
_a9783031112843 _9978-3-031-11284-3 |
||
| 024 | 7 |
_a10.1007/978-3-031-11284-3 _2doi |
|
| 050 | 4 | _aRA1270.N36 | |
| 050 | 4 | _aR857.N34 | |
| 072 | 7 |
_aTBN _2bicssc |
|
| 072 | 7 |
_aMM _2bicssc |
|
| 072 | 7 |
_aTEC021000 _2bisacsh |
|
| 072 | 7 |
_aTBN _2thema |
|
| 072 | 7 |
_aMK _2thema |
|
| 082 | 0 | 4 |
_a620,115 _223 |
| 100 | 1 |
_aMukherjee, Sudip. _eauthor. _4aut _4http://id.loc.gov/vocabulary/relators/aut _986155 |
|
| 245 | 1 | 0 |
_aNanoparticles in Angiogenesis and Cancer _h[electronic resource] / _cby Sudip Mukherjee, Vijay Sagar Madamsetty. |
| 250 | _a1st ed. 2022. | ||
| 264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2022. |
|
| 300 |
_aVIII, 82 p. 27 illus., 10 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aSynthesis Lectures on Biomedical Engineering, _x1930-0336 |
|
| 505 | 0 | _aChapter 1 - Introduction -- Chapter 2 - Current Anti-angiogenic Therapies and their Limitations -- Chapter 3 - Nanomedicine -- Chapter 4 - Organic Nanoparticles in Anti-angiogenic Cancer Therapy -- Chapter 5 - Inorganic Nanoparticles in Anti-angiogenic Cancer Therapy -- Chapter 6 - Potential Challenges in Anti-angiogenic Nanotherapies -- Chapter 7 - Conclusion. | |
| 520 | _aThis book highlights recent developments of organic and inorganic nanomedicine that play a major role in anti-angiogenic cancer therapy. In addition, the authors present examples of nanomedicine based anti-angiogenic agents and their applications in cancer therapy. Angiogenesis is a pathophysiological phenomenon that modulates cell proliferation and cell migration and plays important roles in cancer. Anti-angiogenic nanotherapies have gained immense attention in recent times as alternative cost-effective therapies that opened a new dimension in cancer theranostics. Further the challenges of the anti-angiogenic nanotherapies and possible future perspective are detailed. | ||
| 650 | 0 |
_aNanomedicine. _95252 |
|
| 650 | 0 |
_aNanotechnology. _94707 |
|
| 650 | 0 |
_aCancer. _915213 |
|
| 650 | 0 |
_aBlood-vessels _xGrowth. _986158 |
|
| 650 | 1 | 4 |
_aNanomedicine and Nanotoxicology. _986159 |
| 650 | 2 | 4 |
_aImpact of Nanotechnology. _986161 |
| 650 | 2 | 4 |
_aCancer Nanotechnology. _986162 |
| 650 | 2 | 4 |
_aAngiogenesis. _986164 |
| 700 | 1 |
_aMadamsetty, Vijay Sagar. _eauthor. _4aut _4http://id.loc.gov/vocabulary/relators/aut _986166 |
|
| 710 | 2 |
_aSpringerLink (Online service) _986168 |
|
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031112836 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031112850 |
| 830 | 0 |
_aSynthesis Lectures on Biomedical Engineering, _x1930-0336 _986170 |
|
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-3-031-11284-3 |
| 912 | _aZDB-2-SXSC | ||
| 942 | _cEBK | ||
| 999 |
_c85911 _d85911 |
||